These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 9420635

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The role of neutral endopeptidase in dogs with evolving congestive heart failure.
    Margulies KB, Barclay PL, Burnett JC.
    Circulation; 1995 Apr 01; 91(7):2036-42. PubMed ID: 7895362
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Maximizing the renal cyclic 3'-5'-guanosine monophosphate system with type V phosphodiesterase inhibition and exogenous natriuretic peptide: a novel strategy to improve renal function in experimental overt heart failure.
    Chen HH, Huntley BK, Schirger JA, Cataliotti A, Burnett JC.
    J Am Soc Nephrol; 2006 Oct 01; 17(10):2742-7. PubMed ID: 16928803
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of cGMP-phosphodiesterase restores the glomerular effects of atrial natriuretic factor in low sodium diet rats.
    Kalinowski L, Szczepanska-Konkel M, Pawelczyk T, Bizon D, Angielski S.
    Ren Physiol Biochem; 1995 Oct 01; 18(5):254-66. PubMed ID: 8869083
    [Abstract] [Full Text] [Related]

  • 7. Blunted cGMP response to agonists and enhanced glomerular cyclic 3',5'-nucleotide phosphodiesterase activities in experimental congestive heart failure.
    Supaporn T, Sandberg SM, Borgeson DD, Heublein DM, Luchner A, Wei CM, Dousa TP, Burnett JC.
    Kidney Int; 1996 Nov 01; 50(5):1718-25. PubMed ID: 8914042
    [Abstract] [Full Text] [Related]

  • 8. Cardiorenal actions of neutral endopeptidase inhibition in experimental congestive heart failure.
    Cavero PG, Margulies KB, Winaver J, Seymour AA, Delaney NG, Burnett JC.
    Circulation; 1990 Jul 01; 82(1):196-201. PubMed ID: 2142023
    [Abstract] [Full Text] [Related]

  • 9. Glomerular atrial natriuretic factor receptors in experimental congestive heart failure.
    Isnard R, Carayon A, Eurin J, Maistre G, Bouanani N, Barthelemy C, Crozatier B, Komajda M, Legrand JC.
    Am J Physiol; 1993 Sep 01; 265(3 Pt 2):H923-8. PubMed ID: 8214128
    [Abstract] [Full Text] [Related]

  • 10. Angiotensin inhibition potentiates the renal responses to neutral endopeptidase inhibition in dogs with congestive heart failure.
    Margulies KB, Perrella MA, McKinley LJ, Burnett JC.
    J Clin Invest; 1991 Nov 01; 88(5):1636-42. PubMed ID: 1658047
    [Abstract] [Full Text] [Related]

  • 11. Equimolar doses of atrial and brain natriuretic peptides and urodilatin have differential renal actions in overt experimental heart failure.
    Chen HH, Cataliotti A, Schirger JA, Martin FL, Burnett JC.
    Am J Physiol Regul Integr Comp Physiol; 2005 May 01; 288(5):R1093-7. PubMed ID: 15627648
    [Abstract] [Full Text] [Related]

  • 12. Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptide in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase-coupled receptors.
    Wada A, Tsutamoto T, Matsuda Y, Kinoshita M.
    Circulation; 1994 May 01; 89(5):2232-40. PubMed ID: 7910118
    [Abstract] [Full Text] [Related]

  • 13. Renal response to acute neutral endopeptidase inhibition in mild and severe experimental heart failure.
    Chen HH, Schirger JA, Chau WL, Jougasaki M, Lisy O, Redfield MM, Barclay PT, Burnett JC.
    Circulation; 1999 Dec 14; 100(24):2443-8. PubMed ID: 10595958
    [Abstract] [Full Text] [Related]

  • 14. Natriuretic and antialdosterone actions of chronic oral NEP inhibition during progressive congestive heart failure.
    Martin FL, Stevens TL, Cataliotti A, Schirger JA, Borgeson DD, Redfield MM, Luchner A, Burnett JC.
    Kidney Int; 2005 May 14; 67(5):1723-30. PubMed ID: 15840018
    [Abstract] [Full Text] [Related]

  • 15. Effects of renal neutral endopeptidase inhibition on sodium excretion, renal hemodynamics and neurohormonal activation in patients with congestive heart failure.
    Kimmelstiel CD, Perrone R, Kilcoyne L, Souhrada J, Udelson J, Smith J, de Bold A, Griffith J, Konstam MA.
    Cardiology; 1996 May 14; 87(1):46-53. PubMed ID: 8631044
    [Abstract] [Full Text] [Related]

  • 16. Studies on potential involvement of protein kinase C in glomerular insensitivity to atrial natriuretic factor on low sodium intake.
    Kalinowski L, Szczepańska-Konkel M, Jankowski M, Angielski S.
    Med Sci Monit; 2001 May 14; 7(4):628-34. PubMed ID: 11433187
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Neutral endopeptidase inhibition potentiates the renal actions of atrial natriuretic factor.
    Margulies KB, Cavero PG, Seymour AA, Delaney NG, Burnett JC.
    Kidney Int; 1990 Jul 14; 38(1):67-72. PubMed ID: 2143548
    [Abstract] [Full Text] [Related]

  • 19. Role of endogenous atrial natriuretic factor in acute congestive heart failure.
    Lee ME, Miller WL, Edwards BS, Burnett JC.
    J Clin Invest; 1989 Dec 14; 84(6):1962-6. PubMed ID: 2531762
    [Abstract] [Full Text] [Related]

  • 20. Losartan improves the natriuretic response to ANF in rats with high-output heart failure.
    Abassi ZA, Kelly G, Golomb E, Klein H, Keiser HR.
    J Pharmacol Exp Ther; 1994 Jan 14; 268(1):224-30. PubMed ID: 8301562
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.